Is There a Role for the Therapeutic Drug Monitoring of Colistin? An Overview
Colistin is used as a last-line antibiotic for the treatment of Gram-negative multiresistant bacteria. Due to its high nephrotoxicity, Therapeutic Drug Monitoring (TDM) is recommended for dose adjustment. We aimed to evaluate the available evidence of TDM in patients given colistin to treat Gram-neg...
Saved in:
Main Authors: | Maria-Paula Avila (Author), Tatiana Pacheco (Author), Sara Arias (Author), Rosa-Helena Bustos (Author), Julio-Cesar Garcia (Author), Diego Jaimes (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Estimation of the Difference in Colistin Plasma Levels in Critically Ill Patients with Favorable or Unfavorable Clinical Outcomes
by: Jose Sanabria, et al.
Published: (2021) -
Development and ELISA Characterization of Antibodies against the Colistin, Vancomycin, Daptomycin, and Meropenem: A Therapeutic Drug Monitoring Approach
by: Vivian Garzon, et al.
Published: (2024) -
Impact on Antibiotic Resistance, Therapeutic Success, and Control of Side Effects in Therapeutic Drug Monitoring (TDM) of Daptomycin: A Scoping Review
by: Carolina Osorio, et al.
Published: (2021) -
An Approach to Measuring Colistin Plasma Levels Regarding the Treatment of Multidrug-Resistant Bacterial Infection
by: Tatiana Pacheco, et al.
Published: (2019) -
Challenges of Colistin Use in ICU and Therapeutic Drug Monitoring: A Literature Review
by: Jitka Rychlíčková, et al.
Published: (2023)